Adenine Base Editing in an Adult Mouse Model of Tyrosinaemia
View/ Open
s41551-019-0357-8.pdf (2.045Mb)
Access Status
Full text of the requested work is not available in DASH at this time ("restricted access"). For more information on restricted deposits, see our FAQ.Author
Song, Chun-Qing
Jiang, Tingting
Richter, Michelle
Rhym, Luke H.
Paz Zafra, Maria
Schatoff, Emma M.
Cao, Yueying
Dow, Lukas E.
Zhu, Lihua Julie
Yin, Hao
Xue, Wen
Published Version
https://doi.org/10.1038/s41551-019-0357-8Metadata
Show full item recordCitation
Song, Chun-Qing, Tingting Jiang, Michelle Richter, Luke H. Rhym, Luke Koblan, Maria Paz Zafra, Emma M. Schatoff et al. "Adenine Base Editing in an Adult Mouse Model of Tyrosinaemia." Nature Biomedical Engineering 4, no. 1 (2019): 125-130. DOI: 10.1038/s41551-019-0357-8Abstract
Unlike traditional CRISPR-Cas9 homology-directed repair, base editing can correct point mutations without supplying a DNA-repair template. Here, we show in a mouse model of tyrosinemia that hydrodynamic tail-vein injection of plasmid DNA encoding the adenine base editor (ABE) and a single guide RNA can correct an A>G splice-site mutation. ABE treatment partially restored splicing, generated fumarylacetoacetate hydrolase (Fah)-positive hepatocytes in the liver, and rescued weight loss in the animals. We also generated Fah+ hepatocytes in the liver via lipid-nanoparticle-mediated delivery of chemically modified sgRNA and an mRNA of a codon-optimized base editor that displayed higher base-editing efficiency than the standard ABE. Our findings suggest that adenosine base editing can be used for the correction of genetic disease in adult animals.Other Sources
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6986236/Citable link to this page
https://nrs.harvard.edu/URN-3:HUL.INSTREPOS:37372929
Collections
- HMS Scholarly Articles [17922]
Contact administrator regarding this item (to report mistakes or request changes)